C. Jason Wang

Jason Wang Stanford Health Policy

C. Jason Wang, MD, PhD

  • LCY: Tan Lan Lee Professor
  • Professor, Health Policy
  • Professor Pediatrics (General Pediatrics)
  • Director, Center for Policy, Outcomes & Prevention (CPOP)
  • Co-Director, PCHA-UHA Research & Learning Collaborative
  • Co-Chair, Mobile Health & Other Technologies, Stanford Center for Population Health Sciences
  • Co-Director, Academic General Pediatrics Fellowship

Encina Commons Room 180,
615 Crothers Way,
Stanford, CA 94305-6006

(650) 736-0403 (voice)
(650) 723-1919 (fax)


C. Jason Wang, M.D., Ph.D. is a Professor of Pediatrics and Health Policy and director of the Center for Policy, Outcomes, and Prevention at Stanford University.  He received his B.S. from MIT, M.D. from Harvard, and Ph.D. in policy analysis from RAND.  After completing his pediatric residency training at UCSF, he worked in Greater China with McKinsey and Company, during which time he performed multiple studies in the Asian healthcare market. In 2000, he was recruited to serve as the project manager for the Taskforce on Reforming Taiwan's National Health Insurance System. His fellowship training in health services research included the Robert Wood Johnson Clinical Scholars Program and the National Research Service Award Fellowship at UCLA. Prior to coming to Stanford in 2011, he was an Assistant Professor of Pediatrics and Public Health (2006-2010) and Associate Professor (2010-2011) at Boston University and Boston Medical Center. 

Among his accomplishments, he was selected as the student speaker for Harvard Medical School Commencement (1996).  He received the Overseas Chinese Outstanding Achievement Medal (1996), the Robert Wood Johnson Physician Faculty Scholars Career Development Award (2007), the CIMIT Young Clinician Research Award for Transformative Innovation in Healthcare Research (2010), and the NIH Director’s New Innovator Award (2011). He was recently named a “Viewpoints” editor and a regular contributor for the Journal of the American Medical Association (JAMA).  He served as an external reviewer for the 2011 IOM Report “Child and Adolescent Health and Health Care Quality: Measuring What Matters” and as a reviewer for AHRQ study sections.

Dr. Wang has written two bestselling Chinese books published in Taiwan and co-authored an English book “Analysis of Healthcare Interventions that Change Patient Trajectories”.  His essay, "Time is Ripe for Increased U.S.-China Cooperation in Health," was selected as the first-place American essay in the 2003 A. Doak Barnett Memorial Essay Contest sponsored by the National Committee on United States-China Relations.

Currently he is the principal investigator on a number of quality improvement and quality assessment projects funded by the Robert Wood Johnson Foundation, the National Institutes of Health (USA), Health Resources and Services Administration (HRSA), and the Andrew T. Huang Medical Education Promotion Fund (Taiwan).

Dr. Wang’s research interests include: 1) developing tools for assessing and improving the quality of healthcare; 2) facilitating the use of innovative consumer technology in improving quality of care and health outcomes; 3) studying competency-based medical education curriculum, and 4) improving health systems performance.

In The News

PretermConnect Digital

Preventing Preterm Deliveries Using a Digital Approach

SHP researchers awarded grant to continue their clinical trial testing out a digital app they hope will prevent preterm births.
cover link Preventing Preterm Deliveries Using a Digital Approach
COVID Contact Tracing

Contact-tracing App Curbed Spread of COVID in England and Wales

SHP's Jason Wang writes in this Nature article that digital contact tracing has the potential to limit the spread of COVID-19.
cover link Contact-tracing App Curbed Spread of COVID in England and Wales
COVID-19 research illustration

An Impact-Oriented Approach to COVID-19 Epidemiological Modeling

Epidemiological modeling has emerged as a crucial tool to help decision-makers combat COVID-19, with calls for non-pharmaceutical interventions such as stay-at-home orders and the wearing of masks. But those models have become ubiquitous and part of the public lexicon — so Nirav Shah and Jason Wang write that they should follow an impact-oriented approach.
cover link An Impact-Oriented Approach to COVID-19 Epidemiological Modeling